Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Journal of the American College of Cardiology
|
January 1, 1991
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study Group
A E Arnold, P W Serruys, W Rutsch, et al.
Circulation
|
October 1, 1991
Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT)
P W Serruys, W Rutsch, G R Heyndrickx, et al.
The New England Journal of Medicine
|
August 25, 1994
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group
P W Serruys, P de Jaegere, F Kiemeneij, et al.
Journal of the American College of Cardiology
|
November 18, 2000
Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene
P M Mrozikiewicz, I Cascorbi, S Ziemer, et al.
The New England Journal of Medicine
|
May 26, 1999
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators
C W Hamm, C Heeschen, B Goldmann, et al.
Circulation
|
October 1, 1993
Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial
P W Serruys, W Klein, J P Tijssen, et al.
Heart (British Cardiac Society)
|
May 16, 2003
Clinical and angiographic acute and follow up results of intracoronary beta brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary beta brachytherapy (RENO)
T M Schiele, E Regar, S Silber, et al.
The New England Journal of Medicine
|
December 3, 1998
Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group
R Erbel, M Haude, H W Höpp, et al.
Journal of the American College of Cardiology
|
October 1, 1992
Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis)
W R Hermans, B J Rensing, D P Foley, et al.
The American Journal of Cardiology
|
July 1, 1993
Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups
W R Hermans, D P Foley, B J Rensing, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Journal of the American College of Cardiology
|
January 1, 1991
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study Group
A E Arnold, P W Serruys, W Rutsch, et al.
Circulation
|
October 1, 1991
Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT)
P W Serruys, W Rutsch, G R Heyndrickx, et al.
The New England Journal of Medicine
|
August 25, 1994
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group
P W Serruys, P de Jaegere, F Kiemeneij, et al.
Journal of the American College of Cardiology
|
November 18, 2000
Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene
P M Mrozikiewicz, I Cascorbi, S Ziemer, et al.
The New England Journal of Medicine
|
May 26, 1999
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators
C W Hamm, C Heeschen, B Goldmann, et al.
Circulation
|
October 1, 1993
Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial
P W Serruys, W Klein, J P Tijssen, et al.
Heart (British Cardiac Society)
|
May 16, 2003
Clinical and angiographic acute and follow up results of intracoronary beta brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary beta brachytherapy (RENO)
T M Schiele, E Regar, S Silber, et al.
The New England Journal of Medicine
|
December 3, 1998
Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group
R Erbel, M Haude, H W Höpp, et al.
Journal of the American College of Cardiology
|
October 1, 1992
Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis)
W R Hermans, B J Rensing, D P Foley, et al.
The American Journal of Cardiology
|
July 1, 1993
Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups
W R Hermans, D P Foley, B J Rensing, et al.
Page
of 9